Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).

Patients weighing more than 450 pounds face considerable limitations when attempting to access specialty care.

A new report offers the first state-by-state ranking of how vulnerable individual health and health care systems are to climate risks.

While DTC telehealth companies remove barriers to care for patients, questions remain regarding patient safety and proper education of these products.

Researchers observed an association for inhaled cannabis use with asthma overall and among the 221,767 participants with no lifetime tobacco cigarette use.

The Food and Drug Administration has approved Jascayd for the treatment of idiopathic pulmonary fibrosis in adult patients.

“These results suggest that health care providers should consider testing for loss of smell as a routine part of post- COVID care,” Horwitz said in a statement. “While patients may not notice right ...

The CDC’s Acting Director Jim O’Neill has signed off on immunization schedule updates recommended by the newly appointed Advisory Committee on Immunization Practices.

In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.

Treatments for achondroplasia, acute myeloid leukemia, familial chylomicronemia syndrome, immunoglobulin A nephropathy, and non-small cell lung cancer are under review.

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.

Both pro- and anti-abortion advocacy groups spoke out against the proposed Unborn Child Protection Act at a Senate committee hearing.